Literature DB >> 17726548

Elevated cyclin E level in human clear cell renal cell carcinoma: possible causes and consequences.

Alicja Nauman1, Olga Turowska, Piotr Poplawski, Adam Master, Zbigniew Tanski, Monika Puzianowska-Kuznicka.   

Abstract

The expression of cyclin E gene (CCNE) in relation to the expression of its major regulatory protein, E2F1, was examined in clear cell renal cell carcinomas (ccRCC). We show that the overexpression of E2F1 is accompanied by the significant increase of the mean amounts of cyclin E mRNA, as well as of total cyclin E protein and its low molecular weight forms in cancer tissues as compared to peritumoral controls. A significant increase of the mean amount of total cyclin E was found in peritumoral tissues compared to cancer-free kidneys, suggesting that cancer cells might secrete factors having a profound influence on the metabolism of neighbouring tissues. A significant, positive correlations between E2F1 protein and total cyclin E mRNA, as well as between E2F1 protein and full length cyclin E protein were found in cancer-free kidneys and in peritumoral tissues, but not in ccRCCs. The overexpression of cyclin E positively correlated with the decreasing degree of tumor differentiation, implicating a role for cyclin E in the promotion of tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17726548

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  9 in total

1.  Low molecular weight cyclin E overexpression shortens mitosis, leading to chromosome missegregation and centrosome amplification.

Authors:  Rozita Bagheri-Yarmand; Anna Biernacka; Kelly K Hunt; Khandan Keyomarsi
Journal:  Cancer Res       Date:  2010-06-08       Impact factor: 12.701

Review 2.  Low-Molecular-Weight Cyclin E in Human Cancer: Cellular Consequences and Opportunities for Targeted Therapies.

Authors:  Joseph A Caruso; Mylinh T Duong; Jason P W Carey; Kelly K Hunt; Khandan Keyomarsi
Journal:  Cancer Res       Date:  2018-09-07       Impact factor: 12.701

3.  Cyclin E Associates with the Lipogenic Enzyme ATP-Citrate Lyase to Enable Malignant Growth of Breast Cancer Cells.

Authors:  Kimberly S Lucenay; Iman Doostan; Cansu Karakas; Tuyen Bui; Zhiyong Ding; Gordon B Mills; Kelly K Hunt; Khandan Keyomarsi
Journal:  Cancer Res       Date:  2016-02-29       Impact factor: 12.701

4.  Cytoplasmic Cyclin E Mediates Resistance to Aromatase Inhibitors in Breast Cancer.

Authors:  Iman Doostan; Cansu Karakas; Mehrnoosh Kohansal; Kwang-Hui Low; Matthew J Ellis; John A Olson; Vera J Suman; Kelly K Hunt; Stacy L Moulder; Khandan Keyomarsi
Journal:  Clin Cancer Res       Date:  2017-09-25       Impact factor: 12.531

5.  Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer.

Authors:  Kelly K Hunt; Khandan Keyomarsi; Cansu Karakas; Min Jin Ha; Anna Biernacka; Min Yi; Aysegul A Sahin; Opoku Adjapong; Gabriel N Hortobagyi; Melissa Bondy; Patricia Thompson; Kwok Leung Cheung; Ian O Ellis; Sarah Bacus; W Fraser Symmans; Kim-Anh Do
Journal:  Clin Cancer Res       Date:  2016-11-23       Impact factor: 12.531

6.  Cytoplasmic Cyclin E and Phospho-Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast Cancer.

Authors:  Cansu Karakas; Anna Biernacka; Tuyen Bui; Aysegul A Sahin; Min Yi; Said Akli; Jolie Schafer; Angela Alexander; Opoku Adjapong; Kelly K Hunt; Khandan Keyomarsi
Journal:  Am J Pathol       Date:  2016-05-13       Impact factor: 4.307

7.  PRR11 promotes ccRCC tumorigenesis by regulating E2F1 stability.

Authors:  Siming Chen; Zhiwen He; Tianchen Peng; Fenfang Zhou; Gang Wang; Kaiyu Qian; Lingao Ju; Yu Xiao; Xinghuan Wang
Journal:  JCI Insight       Date:  2021-10-08

8.  Thyroid hormone - triiodothyronine - has contrary effect on proliferation of human proximal tubules cell line (HK2) and renal cancer cell lines (Caki-2, Caki-1) - role of E2F4, E2F5 and p107, p130.

Authors:  Piotr Poplawski; Alicja Nauman
Journal:  Thyroid Res       Date:  2008-10-13

9.  SET7/9 promotes hepatocellular carcinoma progression through regulation of E2F1.

Authors:  Ye Gu; Xinling Wang; Hong Liu; Guimei Li; Weiping Yu; Qing Ma
Journal:  Oncol Rep       Date:  2018-08-02       Impact factor: 3.906

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.